^

Patient Care and Research

Section Menu  

 

Beyond the Beam: A Radiation Oncology Curriculum for Radiopharmaceutical Therapy

 

 

April 26, 3:00 p.m. - 5:00 p.m. Eastern time – Introduction, Radiobiology I and Chemistry

  • Introduction to radiopharmaceutical therapy and curriculum overview – Ana Kiess, MD, PhD
  • Radiobiology I – PK, biodistribution, dose rate, subcellular targeting, molecular and cellular effects of beta/alpha deterministic and stochastic effects, toxicities – Ana Kiess, MD, PhD
  • Chemistry of radiopharmaceutical therapies for medical use – Freddy E. Escorcia, MD, PhD

May 10, 3:00 p.m. - 5:00 p.m. Eastern time – Physics l and Principles of Molecular Imaging

  • Physics I – Image acquisitions and quantitation (PET, SPECT) – Rameshwar Prasad, MS, PhD
  • Principles of clinical molecular imaging for radiopharmaceutical therapy – Vikas Prasad, MD, PhD 

May 17, 3:00 p.m. - 5:00 p.m. Eastern time – Physics ll, lll and IV

  • Physics II – Instrumentation and mathematics pertaining to the use of measurement of radioactivity – Rameshwar Prasad, MS, PhD
  • Physics lll – Radiation protection for radiopharmaceutical therapies – Jessica Clements, MS 
  • Physics IV – Regulatory issues and standard operating procedures – Jacqueline Esthappan Zoberi, PhD 

May 24, 3:00 p.m. - 5:00 p.m. Eastern time – Dosimetry l and ll and Radiobiology II

  • Dosimetry l – Dosimetry methods and individual dose planning uncertainties – Yuni Dewaraja, PhD
  • Dosimetry II/Radiobiology ll – Bioeffect modeling. Tumor dose-response. Toxicities. Alpha emitters – Robert Francois Hobbs, PhD

May 31, 3:00 p.m. - 4:00 p.m. Eastern time – Quality and Safety

  • Principles of patient-centered clinical radiopharmaceutical therapy quality and safety – Hyun Kim, MD

June 7, 3:00 p.m. - 5:00 p.m. Eastern time – Therapy-Specific Considerations l

  • Therapy-specific considerations for Lu-PSMA-617 – Jeff Michalski, MD, MBA, FASTRO
  • Therapy-specific considerations for Ra-223 – Richard G. Stock, MD

June 14, 3:00 p.m. - 5:00 p.m. Eastern time – Therapy-Specific Considerations ll

  • Therapy-specific considerations for RAI – Stephanie Markovina, MD, PhD, and Nikhil Rammohan, MD, PhD
  • Therapy-specific considerations for liver-directed radiopharmaceutical therapy/selective internal radiation therapy – Andrew S. Kennedy, MD

June 28, 3:00 p.m. - 4:00 p.m. Eastern time – Miscellaneous and Future Applications

  • Miscellaneous and future applications of radiopharmaceutical therapy – How to become an authorized user. Meta-iodobenzylguanidine. Rhenium skin cancer therapy. Radiosynoviorthesis. Alpha emitters. Other – Michael Folkert, MD, PhD

July 5, 3:00 p.m. - 4:00 p.m. Eastern time – Therapy-Specific Considerations lll

  • Therapy-specific considerations for Lu-DOTATATE – Hyun Kim, MD
Copyright © 2024 American Society for Radiation Oncology